Consistent with our data, AXL expression diminished STAT1 phosphorylation and MHC class I expression in a mouse mammary tumor model46 and induced mesenchymal transition via TGFß/SNAI1-signaling, leading to the downregulation of MHC class I expression in prostate cancer47. This evidence concerns the gene SNAI1 and breast cancer.